The most critical challenge to making newborn sequencing a reality is genomic variant interpretation at scale.

Register for our upcoming webinar where Genomenon’s Mark Kiel, MD, Ph.D., and Brittnee Jones, Ph.D., discuss how current approaches of interpreting variants one-by-one are impractical when it comes to screening newborns with whole genome sequencing – and how a unique combination of AI-driven technology and expert scientific review has emerged as the only viable way to curate all variants in the human genome. They will then show how variant classification and supporting evidence is presented in the Mastermind® Genomic Search Engine to enable rapid assessment and identification of newborns at risk for developing a rare disease.

LEARN MORE & REGISTER

Mark Kiel, MD, PhD, Chief Scientific Officer Mark is the Chief Scientific Officer at Genomenon, where he oversees the company’s scientific direction and product development.

Brittnee Jones, PhD, Director of Customer Success  With over a decade building and leading customer success teams across the NGS space, Brittnee ensures rapid product adaption and maximal value for Mastermind users.

RESERVE YOUR SPOT

Create your free account today With Mastermind, not only do you have access to 100X more genomic evidence and 20X more variants than other sources, we have the most comprehensive platform to help you find relevant articles and upgrade VUS calls as well. Start with a trial of Professional Edition to get started.

About Genomenon

Genomenon is an AI-driven genomics company that organizes the world’s genomic knowledge to connect patient DNA to scientific research in the diagnosis and development of treatments for patients with rare genetic diseases and cancer.

For more information, visit Genomenon.com